Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2023 Mar 2;42:54. doi: 10.1186/s13046-023-02626-z

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

Guizhi Jia 1,2,#, Yan Wang 1,2,#, Chengjie Lin 1,2,#, Shihui Lai 1,2, Hongliang Dai 1,2, Zhiqian Wang 1,2, Luo Dai 1,2, Huizhao Su 1,2, Yanjie Song 3,4, Naiwen Zhang 3,4, Yukuan Feng 3,4,, Bo Tang 1,2,
PMCID: PMC9979447  PMID: 36864449

Retraction Note: J Exp Clin Cancer Res 40, 299 (2021)

https://doi.org/10.1186/s13046-021-02090-7

The Editor in Chief has retracted this article. After publication, concerns were raised about an apparent partial overlap between the leftmost SNU-449 migration panel in Fig. 2C and the top LNCAROD+2-DG panel in Fig. 4G. The authors were unable to provide a satisfactory set of raw data on request. Additionally, the issues regarding the provenance of cell lines were not completely resolved in the published version of the article. The editor, therefore, has lost confidence in the integrity of the findings of this article. The authors have not explicitly stated that they agree to this retraction.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Guizhi Jia, Yan Wang and Chengjie Lin contributed equally to this work.

Contributor Information

Yukuan Feng, Email: fengyukuan@163.com.

Bo Tang, Email: dr_sntangbo@163.com.


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES